"Rise of JN.1: The New COVID Variant's Spread and Unique Symptoms"
Israel has reported approximately 200 cases of a new COVID-19 sub-variant named JN.1, which is contributing to a slight increase in morbidity rates. The CDC has warned of its rapid spread and potential impact on hospitalizations, although early data indicates current vaccines may be less effective against it. The WHO expert group believes the changes in JN.1 do not necessitate a new vaccine formula at this time.